UnitedHealth Group Incorporated (UNH) Expected to Post Quarterly Sales of $50.31 Billion
Wall Street analysts expect UnitedHealth Group Incorporated (NYSE:UNH) to announce sales of $50.31 billion for the current quarter, according to Zacks. Six analysts have made estimates for UnitedHealth Group’s earnings. The highest sales estimate is $50.59 billion and the lowest is $50.08 billion. UnitedHealth Group reported sales of $46.29 billion in the same quarter last year, which would suggest a positive year-over-year growth rate of 8.7%. The business is expected to announce its next quarterly earnings report on Tuesday, October 17th.
On average, analysts expect that UnitedHealth Group will report full-year sales of $50.31 billion for the current fiscal year, with estimates ranging from $200.17 billion to $201.24 billion. For the next fiscal year, analysts forecast that the company will report sales of $219.41 billion per share, with estimates ranging from $217.31 billion to $221.86 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that that provide coverage for UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm’s revenue was up 7.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.96 earnings per share.
Several research firms have commented on UNH. Cantor Fitzgerald restated a “buy” rating and issued a $205.00 target price on shares of UnitedHealth Group in a research report on Friday, July 7th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $190.00 price objective on shares of UnitedHealth Group in a report on Monday, July 10th. Credit Suisse Group reiterated an “outperform” rating and issued a $200.00 price objective (up from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Citigroup Inc. increased their price objective on shares of UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. Finally, Royal Bank Of Canada reiterated a “buy” rating and issued a $212.00 price objective on shares of UnitedHealth Group in a report on Thursday, July 20th. One equities research analyst has rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $203.41.
ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group Incorporated (UNH) Expected to Post Quarterly Sales of $50.31 Billion” was published by Daily Political and is the property of of Daily Political. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/09/15/unitedhealth-group-incorporated-unh-expected-to-post-quarterly-sales-of-50-31-billion.html.
In related news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the sale, the director now owns 60,834 shares in the company, valued at approximately $12,135,774.66. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. In the last 90 days, insiders sold 25,600 shares of company stock valued at $4,962,694. 0.89% of the stock is owned by insiders.
Several large investors have recently modified their holdings of UNH. Harbour Capital Advisors LLC lifted its position in shares of UnitedHealth Group by 18,383.4% in the 2nd quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after acquiring an additional 2,503,090 shares in the last quarter. Janus Henderson Group PLC increased its stake in UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after buying an additional 2,264,242 shares during the period. Vanguard Group Inc. increased its stake in UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after buying an additional 1,588,516 shares during the period. Parametric Portfolio Associates LLC increased its stake in UnitedHealth Group by 77.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after buying an additional 1,562,661 shares during the period. Finally, Jennison Associates LLC increased its stake in UnitedHealth Group by 180.4% in the 2nd quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock valued at $417,660,000 after buying an additional 1,449,130 shares during the period. Institutional investors and hedge funds own 86.21% of the company’s stock.
Shares of UnitedHealth Group (NYSE:UNH) traded up 0.23% during midday trading on Tuesday, reaching $198.18. 4,198,691 shares of the company were exchanged. The company’s 50-day moving average price is $195.28 and its 200 day moving average price is $180.64. The stock has a market capitalization of $191.61 billion, a price-to-earnings ratio of 23.81 and a beta of 0.63. UnitedHealth Group has a 52-week low of $133.03 and a 52-week high of $200.76.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be given a $0.75 dividend. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.51%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.